Doljak B - Search Results

1

Cathepsin X cleaves the C-terminal dipeptide of alpha- and gamma-enolase and impairs survival and neuritogenesis of neuronal cells.

Obermajer N, Doljak B, Jamnik P, Fonović UP, Kos J. Obermajer N, et al. Among authors: doljak b. Int J Biochem Cell Biol. 2009 Aug-Sep;41(8-9):1685-96. doi: 10.1016/j.biocel.2009.02.019. Epub 2009 Mar 6. Int J Biochem Cell Biol. 2009. PMID: 19433310

2

Cysteine cathepsins: regulators of antitumour immune response.

Obermajer N, Doljak B, Kos J. Obermajer N, et al. Among authors: doljak b. Expert Opin Biol Ther. 2006 Dec;6(12):1295-309. doi: 10.1517/14712598.6.12.1295. Expert Opin Biol Ther. 2006. PMID: 17223738 Review.

3

Monoclonal antibody to cytokeratin VKIALEVEIATY sequence motif reduces plasminogen activation in breast tumour cells.

Doljak B, Obermajer N, Jamnik P, Kos J. Doljak B, et al. Cancer Lett. 2008 Aug 18;267(1):75-84. doi: 10.1016/j.canlet.2008.03.006. Epub 2008 Apr 22. Cancer Lett. 2008. PMID: 18433993

4

Role of cysteine cathepsins in matrix degradation and cell signalling.

Obermajer N, Jevnikar Z, Doljak B, Kos J. Obermajer N, et al. Among authors: doljak b. Connect Tissue Res. 2008;49(3):193-6. doi: 10.1080/03008200802143158. Connect Tissue Res. 2008. PMID: 18661341 Review.

5

Cathepsin X-mediated beta2 integrin activation results in nanotube outgrowth.

Obermajer N, Jevnikar Z, Doljak B, Sadaghiani AM, Bogyo M, Kos J. Obermajer N, et al. Among authors: doljak b. Cell Mol Life Sci. 2009 Mar;66(6):1126-34. doi: 10.1007/s00018-009-8829-8. Cell Mol Life Sci. 2009. PMID: 19194656 Free PMC article.

6

Inactivation of harmful tumour-associated proteolysis by nanoparticulate system.

Kos J, Obermajer N, Doljak B, Kocbek P, Kristl J. Kos J, et al. Among authors: doljak b. Int J Pharm. 2009 Nov 3;381(2):106-12. doi: 10.1016/j.ijpharm.2009.04.037. Epub 2009 May 5. Int J Pharm. 2009. PMID: 19422896

7

Regulation of cathepsin B activity by 2A2 monoclonal antibody.

Mirković B, Premzl A, Hodnik V, Doljak B, Jevnikar Z, Anderluh G, Kos J. Mirković B, et al. Among authors: doljak b. FEBS J. 2009 Sep;276(17):4739-51. doi: 10.1111/j.1742-4658.2009.07171.x. Epub 2009 Jul 27. FEBS J. 2009. PMID: 19656187 Free article.

8

Cytokeratin 8 ectoplasmic domain binds urokinase-type plasminogen activator to breast tumor cells and modulates their adhesion, growth and invasiveness.

Obermajer N, Doljak B, Kos J. Obermajer N, et al. Among authors: doljak b. Mol Cancer. 2009 Oct 21;8:88. doi: 10.1186/1476-4598-8-88. Mol Cancer. 2009. PMID: 19845941 Free PMC article.

9

A dodecapeptide deduced from cytokeratin sequence strongly enhances uPA/tPA-mediated plasminogen activation.

Obermajer N, Doljak B, Pohleven J, Kos J. Obermajer N, et al. Among authors: doljak b. Br J Haematol. 2010 Jul;150(1):121-4. doi: 10.1111/j.1365-2141.2010.08169.x. Epub 2010 Apr 4. Br J Haematol. 2010. PMID: 20377592 Free article. No abstract available.

10

Cathepsin X cleavage of the beta2 integrin regulates talin-binding and LFA-1 affinity in T cells.

Jevnikar Z, Obermajer N, Doljak B, Turk S, Gobec S, Svajger U, Hailfinger S, Thome M, Kos J. Jevnikar Z, et al. Among authors: doljak b. J Leukoc Biol. 2011 Jul;90(1):99-109. doi: 10.1189/jlb.1110622. Epub 2011 Mar 31. J Leukoc Biol. 2011. PMID: 21454358

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23 results

Search Page

Filters